194
Participants
Start Date
June 6, 2020
Primary Completion Date
November 5, 2020
Study Completion Date
November 5, 2020
Latanoprost ophthalmic solution
Latanoprost opthalmic solution to be dosed once daily
AKB-9778 4%
Razuprotafib opthalmic solution
Placebo
placebo for razuprotafib opthalmic solution
North Valley Eye Medical Group, Rochester
Scott & Christie and Assoc, Cranberry Township
Eye Care Specialists, Kingston
James D. Branch, MD Ophthalmology, Winston-Salem
Charlotte Eye, Ear, Nose & Throat Assoc. (CEENTA), Charlotte
Coastal Research Associates, Roswell
Clayton Eye Clinical Research, LLC, Morrow
Shettle Eye Research, Largo
Advancing Vision Research, Nashville
Total Eye Care, Memphis
Abrams Eye Center, Cleveland
Apex Eye, Cincinnati
Tekwani Vision Center, St Louis
Heart of America Eye Care, P.A., Shawnee Mission
Kannarr Eye Care, Pittsburg
Mark J. Weiss, MD, Inc., Tulsa
Texan Eye / Keystone Research, Austin
United Medical Research Institute, Inglewood
North Valley Eye Medical Group, Mission Hills
Eye Research Foundation, Newport Beach
North Bay Eye Associates, Petaluma
Lead Sponsor
EyePoint Pharmaceuticals, Inc.
INDUSTRY